Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease (2024)
- Authors:
- USP affiliated authors: DUARTE, SIMONE MICHELAN - IFSC ; ANDRICOPULO, RENATA KROGH - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; FERREIRA, LEONARDO LUIZ GOMES - IFSC ; SOUZA, MARIANA LAUREANO DE - IFSC ; CHELUCCI, RAFAEL CONSOLIN - IFSC ; VALLI, MARILIA - IFSC ; OLIVEIRA, ALDO SENA DE - IFSC
- Unidade: IFSC
- DOI: 10.1002/cmdc.202400293
- Subjects: TRYPANOSOMA CRUZI; PLANEJAMENTO DE FÁRMACOS; DOENÇAS PARASITÁRIAS; FÁRMACOS
- Keywords: Benzimidazoles; Chagas disease; Drug design; Hit-to-lead exploration; Metabolic stability; Trypanosoma cruzi
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: ChemMedChem
- ISSN: 1860-7187
- Volume/Número/Paginação/Ano: v. 19, n. 20, p. e202400293, Oct. 2024
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ESPINOZA-CHÁVEZ, Rocío Marisol et al. Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease. ChemMedChem, v. 19, n. 20, p. e202400293, 2024Tradução . . Disponível em: https://doi.org/10.1002/cmdc.202400293. Acesso em: 25 dez. 2025. -
APA
Espinoza-Chávez, R. M., Rezende Junior, C. de O., Souza, M. L. de, Chelucci, R. C., Duarte, S. M., Krogh, R., et al. (2024). Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease. ChemMedChem, 19( 20), e202400293. doi:10.1002/cmdc.202400293 -
NLM
Espinoza-Chávez RM, Rezende Junior C de O, Souza ML de, Chelucci RC, Duarte SM, Krogh R, Ferreira LLG, Valli M, Oliveira AS de, Andricopulo AD, Dias LC. Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease [Internet]. ChemMedChem. 2024 ; 19( 20): e202400293.[citado 2025 dez. 25 ] Available from: https://doi.org/10.1002/cmdc.202400293 -
Vancouver
Espinoza-Chávez RM, Rezende Junior C de O, Souza ML de, Chelucci RC, Duarte SM, Krogh R, Ferreira LLG, Valli M, Oliveira AS de, Andricopulo AD, Dias LC. Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease [Internet]. ChemMedChem. 2024 ; 19( 20): e202400293.[citado 2025 dez. 25 ] Available from: https://doi.org/10.1002/cmdc.202400293 - Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-trypanosoma cruzi activity
- Convergent synthesis of proline-functionalized pyrazolopyrimidines as anti-T. cruzi bioactive compounds
- Indoles hit-to-lead for chagas disease: lessons learned within the LOLA consortium
- Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease
- Discovery of arylpiperazines with broad-spectrum antimicrobial activity and favorable pharmacokinetic profiles
- Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents
- Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum
- Antitrypanosomal aminobenzimidazoles: hit to lead expansion of new chemical entities against Trypanosoma cruzi and Leishmania infantum
- Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies
- Antitrypanosomal Benzoxazinone series: hit-to-lead campaign and multiparametric optimization
Informações sobre o DOI: 10.1002/cmdc.202400293 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
